HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

bis(1,2- (methacryloyloxy)dodecanoyl)phosphatidylcholine

Also Known As:

BMDPC; bis(1,2-methacryloyloxy)dodecanoyl-sn-glycero-3-phosphocholine

Networked: 3 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Lipids: 114793
- Membrane Lipids: 1591
  - Phospholipids: 11903
    - Glycerophosphates: 118
      - Phosphatidic Acids: 358
        Glycerophospholipids: 689
        Phosphatidylcholines: 2371
        bis(1,2-(methacryloyloxy)dodecanoyl)phosphatidylcholine: 3

Experts

1.	Beck, Grietje: 2 articles (01/2019 - 09/2014)
2.	Rafat, Neysan: 2 articles (01/2019 - 09/2014)
3.	Tönshoff, Burkhard: 2 articles (01/2019 - 09/2014)
4.	Yard, Benito: 2 articles (01/2019 - 09/2014)
5.	Hillenbrand, Alexander: 1 article (01/2019)
6.	Krebs, Jörg: 1 article (01/2019)
7.	Patry, Christian: 1 article (01/2019)
8.	Tsagogiorgas, Charalambos: 1 article (01/2019)
9.	Betzen, Christian: 1 article (09/2014)
10.	Dacho, Christine: 1 article (09/2014)

Related Diseases

1.	Sepsis (Septicemia) 01/01/2019 - "Cell-based therapies with bone marrow-derived progenitor cells (BMDPC) lead to an improved clinical outcome in animal sepsis models. " 01/01/2019 - "In the present study we evaluated the ability of granulocyte macrophage-colony stimulating factor (GM-CSF) to mobilize BMDPC in a lipopolysaccharide (LPS)-induced sepsis model and thereby its potential as a novel treatment strategy. "
2.	Weight Loss (Weight Reduction) 01/01/2019 - "In vivo, rats receiving both LPS and GM-CSF, showed a reduced weight loss and increased mobilization of BMDPC. " 09/08/2014 - "Rats treated with BMDPC showed significantly reduced histopathological changes, a reduced expression of ICAM-1 and VCAM-1 by the lung tissue, an inhibition of proinflammatory cytokine synthesis, a reduced weight loss and a reduced mortality (p < 0.03) compared to rats treated with LPS alone. "
3.	Inflammation (Inflammations) 09/08/2014 - "These findings suggest that the application of exogenous BMDPC can attenuate inflammation in LPS-induced ARDS and thereby reduce the severity of septic organ damage. "
4.	Infarction (Infarctions) 07/30/2004 - "The vascular network formed at the infarct site contains a ratio of conduit to exchange vessels that is greater than that for control tissue and therefore its ability to nourish BMDPC for their growth appears to be tenuous. " 07/30/2004 - "The potential for bone marrow-derived progenitor cells (BMDPC) to regenerate myocardial tissue following infarction depends on homing, migration, nourishment, and spatially appropriate growth of BMDPC. "
5.	Cicatrix (Scar) 07/30/2004 - "These findings, together with the dense formation of a fibrillar collagen scar beyond week 2, suggest the optimal time to rebuild myocardium from BMDPC resides within 2 week postMI."

Related Drugs and Biologics

1.	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
2.	Lipopolysaccharides
3.	Fibrillar Collagens
4.	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)
5.	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)
6.	Cytokines

Related Therapies and Procedures

1.	Therapeutics